Opening of cutting-edge biomanufacturing facility creates more than 1,000 Canadian jobs, boosting the domestic life sciences sector
The Government of Canada is investing in a robust, dynamic and resilient life sciences ecosystem capable of responding to current and future health emergencies. Since March 2020, over $2.2 billion has been invested to strengthen our country's domestic biomanufacturing and life sciences capabilities to ensure Canadians have access to the most cutting-edge medical technologies.
Today, the Honourable François-Philippe Champagne, Minister of Innovation, Science and Industry, is pleased to announce the opening of STEMCELL Technologies' state-of-the-art facility, in Burnaby, British Columbia, which has been supported through a $22.5 million investment by the Government of Canada, matched by the Government of British Columbia. This investment has contributed to the construction of a brand new good manufacturing practices (GMP) biomanufacturing facility where STEMCELL Technologies can now manufacture products at the higher regulatory compliance standard required to support clinical trials for cell therapy, tissue engineering, immunotherapy, gene therapy and regenerative medicine, with the ultimate aim of curing cancer and other serious diseases. With the completion of this project, STEMCELL Technologies created more than 1,000 new full-time jobs in British Columbia, far exceeding the project's target of 675.
The expansion of STEMCELL Technologies' presence in British Columbia strengthens the province's status as a biomanufacturing and life sciences hub and will generate more research and development (R&D) and more collaboration with academia. It will also ensure new intellectual property being developed remains in Canada.
This investment is made possible through the Strategic Innovation Fund, a program to attract and support high-quality business investments across all sectors of the economy by encouraging R&D that will accelerate technology transfer and commercialization of innovative products, processes and services.